Onconic Therapeutics Inc. (KOSDAQ:476060)
17,990
-40 (-0.22%)
Sep 1, 2026, 3:30 PM KST
170.02% (1Y)
| Market Cap | 816.89B +177.1% |
| Revenue (ttm) | 82.17B +179.3% |
| Net Income | 24.25B +430.5% |
| EPS | n/a |
| Shares Out | 45.41M |
| PE Ratio | 33.68 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,983,758 |
| Open | 17,430 |
| Previous Close | 18,030 |
| Day's Range | 16,900 - 18,440 |
| 52-Week Range | 6,463 - 28,900 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 6, 2026 |